Vaccine effectiveness against influenza-associated hospitalizations in adults with liver disease, 2015–2020: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)

Vaccine effectiveness against influenza-associated hospitalizations in adults with liver disease, 2015–2020: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)

Influenza causes 100,000–710,000 hospitalizations annually in the U.S. Patients with liver disease are at higher risk of severe outcomes following influenza infection. This study evaluated influenza vaccine effectiveness (VE) against influenza-associated hospitalization among adults with liver disea...

Full description

Saved in:
Bibliographic Details
Main Authors: Po-Han Huang, Mary Patricia Nowalk, Richard K. Zimmerman, Samantha M. Olson, H. Keipp Talbot, Yuwei Zhu, Manjusha Gaglani, Kempapura Murthy, Arnold S. Monto, Emily T. Martin, Fernanda P. Silveira, G.K. Balasubramani
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Influenza
vaccine
vaccine effectiveness
liver disease
immunocompromised
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2025.2457205
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items